The benefits from giving makers of conventional 'small molecule' drugs longer exclusivity over clinical trial data
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Dana Goldman Darius Lakdawalla |
| Publication date | January 1, 2011 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |